(
out of
98
reviews
)
Specialties
Board Certification
|
National Board of Medical Examiners
|
Patient Rating
Patients consistently praise Dr. Callis for strong clinical knowledge, thoroughness, and helpful care coordination, with several noting she reduces medication costs and leverages staff effectively. Many describe her as professional, personable, and effective at teaching trainees while providing clear follow-up and responsive communication. A minority of comments raise concerns about communication style and privacy — some found explanations overly technical or felt she could seem stern or defensive, and a few were uncomfortable with the positioning of assistants or trainees during exams. Overall the feedback is predominantly positive, with occasional issues related to clarity and perceived receptiveness.
Generated via Patient Reviews
4.9
/5
( out of
98 reviews
)
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Board Certification and Academic Information
| Academic Departments |
Dermatology
-Professor |
|---|---|
| Board Certification |
National Board of Medical Examiners
|
Education history
| Undergraduate | Biomedical Sciences - Montana State University | B.S. |
|---|---|---|
| Professional Medical | Medicine - University of Washington | M.D. |
| Residency | Internal Medicine - Maine Medical Center | Resident |
| Chief Resident | Internal Medicine - Maine Medical Center | Chief Resident |
| Fellowship | Dermatology - University of Utah School of Medicine | Fellow |
| Residency | Dermatology - University of Utah School of Medicine | Resident |
| Graduate Training | Clinical Investigation - University of Utah | M.S.C.I |
| Certification | Health Science Leadership Development Program - University of Utah | Certificate |
Selected Publications
Journal Article
- Armstrong AW, Lee K, Yee D, Woodbury M, Zundell M, Zagona-Prizio C, Yousif J, Grant C, Shields A, Chou P, Callis Duffin K, Gottlieb AB, Merola JF, Perez-Chada (2025). Validation of DermSat-7 for Assessing Treatment Satisfaction in Patients With Psoriasis. JAMA dermatology,
- Armstrong AW, Gondo GC, Merola JF, Roberts AM, Pérez-Chada LM, Balak DMW, Eakin GS, Read C, Le ST, Gutierrez Y, Bhutani T, Blauvelt A, Duffin KC, Fakharzadeh S, Feldman SR, Gelfand JM, Gladman DD, Glick B, Green LJ, Han G, Hawkes JE, Hwang ST, Johnsen N, Kalb RE, Kircik L, Langley RG, Lebwohl MG, Lewitt GM, Maverakis E, Prussick R, Reddy SM, Rosen CF, Scher JU, Siegel EL, Wallace EB, Weinberg JM, Yamauchi PS, Yosipovitch G, Liao W, Remission Workgroup of the National Psoriasis Foundatio (2025). Defining On-Treatment Remission in Plaque Psoriasis: A Consensus Statement From the National Psoriasis Foundation. JAMA dermatology,
- Gkini MA, Chinchay L, Lindsay CA, Franco M, Castro Ayarza JR, Duffin K (2025). Diagnosis and Assessment of Psoriasis for the Rheumatologist: A Workshop From the GRAPPA 2024 Annual Meeting. The Journal of rheumatology, 52(Suppl 3), 19-22.
- Ney Z, Ringwood D, Takara M, Frost Z, Conley M, Kean J, Secrest A, Duffin KC, Hopkins (2025). Clinical assessment implications from core outcome domain set development exercises in dermatology. Journal of the American Academy of Dermatology,
- Blauvelt A, Prussick R, Merola JF, Shahriari M, Cather J, Eakin GS, McCormick Howard L, Lebwohl MG, Armstrong AW, Duffin K (2025). Clarifying psoriasis disease severity: A position statement from the National Psoriasis Foundation Medical Board. Journal of the American Academy of Dermatology,
- Duffin KC, Griffiths CEM, Hoffmann M, Blauvelt A, Balagula Y, Napoli A, Becker B, Jou YM, Dyme R, Hala V, Pinter A, Thaçi D, Gold LS, Lebwohl (2025). Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, in patients with moderate to severe scalp psoriasis: Efficacy and safety results through week 16 in a phase 3b/4, multicenter, randomized, double-blinded, placebo-controlled trial (PSORIATYK SCALP). JAAD international, 25, 28-40.
- Strober B, Duffin KC, Lebwohl M, Sima A, Janak J, Patel M, Photowala H, Garg V, Bagel (2024). Impact of psoriasis disease severity and special area involvement on patient-reported outcomes in the real world: an analysis from the CorEvitas psoriasis registry. The Journal of dermatological treatment, 35(1), 2287401.
- Garg A, Noe MH, Anadkat MJ, Armstrong A, Bhutani T, Farberg A, Han G, Hawkes JE, Lebwohl M, Rekhtman S, Song EJ, Strunk A, Duffin K (2024). Development of the Generalized Pustular Psoriasis Clinical Assessment Tool. Journal of the American Academy of Dermatology, 90(1), 192-195.
- Chat VS, Ellebrecht CT, Kingston P, Bell S, Gondo G, Cordoro KM, Desai SR, Duffin KC, Feldman SR, Garg A, Gelfand JM, Gladman D, Green LJ, Gudjonsson J, Han G, Hawkes JE, Kircik L, Koo J, Langley R, Lebwohl M, Michael Lewitt G, Liao W, Martin G, Orbai AM, Reddy SM, Richardson V, Ritchlin CT, Schwartzman S, Siegel EL, Van Voorhees AS, Wallace EB, Weinberg JM, Winthrop KL, Yamauchi P, Armstrong A (2024). Vaccination Recommendations for Adults Receiving Biologics and Oral Therapies for Psoriasis and Psoriatic Arthritis: Delphi Consensus from the Medical Board of the National Psoriasis Foundation. Journal of the American Academy of Dermatology,
- Carroll C, Aðalsteinsson J, Prouty M, Duffin KC, Krueger GG, Walsh JA, Feng B (2024). Measuring Psoriasis Severity at Home. Journal of visualized experiments, (205),
- Rhoads JLW, Malatestinic WN, Burge R, Ganz ML, Duffin K (2024). Factors Associated With Treatment Escalation for Psoriasis: An Analysis of Electronic Health Records Data. Journal of psoriasis and psoriatic arthritis, 9(1), 5-15.
- Liao W, Armstrong AW, Duffin K (2024). GRAPPA Debate: Targeted Small Molecules Versus Biologics as First-Line Systemic Therapy After Conventional Therapy for Moderate-to-Severe Psoriasis. The Journal of rheumatology, 51(Suppl 2), 89-92.
- Carroll C, Adalsteinsson JA, Prouty M, Duffin KC, Krueger GG, Walsh JA, Feng B (2024). Erratum: Measuring Psoriasis Severity at Home. Journal of visualized experiments, (213),
- Gelfand JM, Armstrong AW, Lim HW, Feldman SR, Johnson SM, Claiborne WCC, Kalb RE, Jakus J, Mangold AR, Flowers RH, Bhutani T, Durkin JR, Bagel J, Fretzin S, Sheehan MP, Krell J, Reeder M, Kaffenberger J, Kartono F, Takeshita J, Bridges AM, Fielding E, Nehal US, Schaecher KL, Howard LM, Eakin GS, Báez S, Bishop BE, Fitzsimmons RC Jr, Papadopoulos M, Song WB, Linn KA, Hubbard RA, Shin DB, Callis Duffin (2024). Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical Trial. JAMA dermatology, 160(12), 1320-1328.
- Gold LS,Papp K,Pariser D,Bhatia N,Sofen H,Albrecht L,Gooderham M,Duffin KC,Chen M,Paris M,Cheng S,Picard H,Wang Y,Green (2023). Efficacy and safety of apremilast in patients with mild-to-moderate psoriasis up to 32 weeks: Results from the extension phase of the randomized, phase 3 ADVANCE trial. Journal of the American Academy of Dermatology, 88(2), 430-433.
- Armstrong AW,Fitzgerald T,McLean RR,Teeple A,Uy JP,Olurinde M,Rowland K,Guo L,Shan Y,Callis Duffin (2023). Effectiveness of Guselkumab Therapy among Patients with Plaque Psoriasis with Baseline IGA Score ¿ 2 in the CorEvitas Psoriasis Registry. Dermatology and therapy, 13(2), 487-504.
- Armstrong AW,Fitzgerald T,McLean RR,Teeple A,Uy JP,Olurinde M,Rowland K,Guo L,Shan Y,Callis Duffin (2023). Real-World Effectiveness of 9¿12 Months of Guselkumab Therapy among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry. Dermatology and therapy, 13(2), 629-640.
- Burden AD, Bachelez H, Choon SE, Marrakchi S, Tsai TF, Turki H, Morita A, Lebwohl MG, Bissonnette R, Zheng M, Anadkat MJ, Alexander AN, Tang M, Thoma C, Duffin K (2023). The Generalized Pustular Psoriasis Physician Global Assessment (GPPGA) score: online assessment and validation study of a specific measure of GPP disease activity. The British journal of dermatology,
- Strober B, Ferris L, Duffin KC, Janak JC, Sima AP, Eckmann T, Patel M, Photowala H, Garg V, Armstrong (2023). Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis using the CorEvitas Psoriasis Registry. Journal of the American Academy of Dermatology,
- Walsh JA, Carroll C, Callis Duffin K, Wang J, Krueger GG, Feng B (2023). PAPRIKA: A Question Bank for Assessing Psoriatic Arthritis Risk in Individuals of Diverse Ancestries. Arthritis care & research, 76(3), 421-425.
- Callis Duffin K, Hwang ST, Krueger J (2023). Advances and Controversies in Our Understanding of Guttate and Plaque Psoriasis. The Journal of rheumatology,
- Ng BCK, Jadon D, Adebajo A, Ayan G, Callis Duffin K, Chandran V, Coates LC, D'Agostino MA, de Vlam K, Deodhar A, Eder L, Garg A, Gladman DD, Goel N, Gottlieb AB, Husni ME, Katz A, Kavanaugh A, Lubrano E, Mease PJ, Merola JF, Nash P, Ogdie A, Pennington SR, Perez-Chada LM, Proft F, Rosen CF, Savage L, Goldenstein-Schainberg C, Siebert S, Soriano ER, Steinkoenig I, Tillett W, Armstrong AW, FitzGerald (2023). Proceedings of the GRAPPA 2022 Executive Retreat. The Journal of rheumatology,
- Armstrong AW, Fitzgerald T, McLean RR, Teeple A, Uy JP, Olurinde M, Rowland K, Guo L, Shan Y, Callis Duffin (2023). The Effectiveness of Guselkumab by BMI Category Among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry. Advances in therapy, 40(5), 2493-2508.
- Stein Gold L,Papp K,Pariser D,Green L,Bhatia N,Sofen H,Albrecht L,Gooderham M,Chen M,Paris M,Wang Y,Callis Duffin (2022). Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial. Journal of the American Academy of Dermatology, 86(1), 77-85.
- Walsh JA,Callis Duffin K,Van Voorhees AS,Chakravarty SD,Fitzgerald T,Teeple A,Rowland K,Uy J,McLean RR,Malley W,Cronin A,Merola J (2022). Demographics, Disease Characteristics, and Patient-Reported Outcomes Among Patients with Psoriasis Who Initiated Guselkumab in CorEvitas¿ Psoriasis Registry. Dermatology and therapy, 12(1), 97-119.
- Noe MH,Wan MT,Mostaghimi A,Gelfand JM,Agnihothri R,Armstrong AW,Bhutani T,Bridges A,Brownstone N,Butt M,Duffin KPC,Carr C,Creadore A,Deniro KL,Desai S,Dominguez AR,Duffy EK,Fairley JA,Femia A,Gudjonsson JE,Kaffenberger JA,Katz KL,Le ST,Martinez E,Maverakis E,Myers B,Naik HB,Nelson CA,Ortega-Loayza AG,Plovanich ME,Rangel LK,Ravi V,Reddy VD,Saleh JZ,Kirby JS,Sandhu JK,Shakshouk H,Shields BE,Sharif-Sidi Z,Smith J,Steahr A,Toussi A,Wanat KA,Wang B,Wei BM,Weinhammer A,Worswick SD,Yang (2022). Evaluation of a Case Series of Patients with Generalized Pustular Psoriasis in the United States. JAMA dermatology, 158(1), 73-78.
- Ogdie A,Lindsay CA,Mease PJ,Duffin KC,Rosen CF,Siebert (2022). Challenges in the Diagnosis and Assessment of Psoriatic Arthritis. The Journal of rheumatology, 49(6), 64-67.
- Duffin KC,Gladman DD,Goel N,Gottlieb AB,FitzGerald O,McFarland L (2022). Prologue: 2021 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Journal of rheumatology, 49(6), 1-3.
- Armstrong AW,Reddy RM,FitzGerald O,Duffin KC,Helliwell PS,Mease PJ,Kavanaugh A,Merola JF,Tillet W,Wit M (2022). 2021 GRAPPA Meet the Experts Session: A Summary of Presentations. The Journal of rheumatology, 49(6), 32-36.
- Takeshita J,Chau J,Duffin KC,Goel (2022). Promoting Diversity, Equity, and Inclusion for Psoriatic Diseases. The Journal of rheumatology, 49(6), 48-51.
- Coates LC,Soriano ER,Corp N,Bertheussen H,Callis Duffin K,Campanholo CB,Chau J,Eder L,Fernández-Ávila DG,FitzGerald O,Garg A,Gladman DD,Goel N,Helliwell PS,Husni ME,Jadon DR,Katz A,Laheru D,Latella J,Leung YY,Lindsay C,Lubrano E,Mazzuoccolo LD,Mease PJ,O'Sullivan D,Ogdie A,Olsder W,Palominos PE,Schick L,Steinkoenig I,de Wit M,van der Windt DA,Kavanaugh A,Campanholo CB,Fitzgerald O,Gladman D,Helliwell P,Husni ME,Laheru D,Leung YY,Lubrano E,Mazzuoccolo LD,Mease PJ,Ogdie A,Palominos P (2022). Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nature reviews. Rheumatology, 18(8), 465-479.
- Coates LC,Soriano ER,Corp N,Bertheussen H,Callis Duffin K,Campanholo CB,Chau J,Eder L,Fernández-Ávila DG,FitzGerald O,Garg A,Gladman DD,Goel N,Helliwell PS,Husni ME,Jadon DR,Katz A,Laheru D,Latella J,Leung YY,Lindsay C,Lubrano E,Mazzuoccolo LD,Mease PJ,O'Sullivan D,Ogdie A,Olsder W,Palominos PE,Schick L,Steinkoenig I,de Wit M,van der Windt DA,Kavanaugh A,Campanholo CB,Fitzgerald O,Gladman D,Helliwell P,Husni ME,Laheru D,Leung YY,Mazzuoccolo LD,Mease PJ,Ogdie A,Palominos P (2022). Author Correction: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021 (Nature Reviews Rheumatology, (2022), 18, 8, (465-479), 10.1038/s41584-022-00798-0). Nature reviews. Rheumatology, 18(12), 734.
- Hopkins ZH, Kuceki G, Taliercio VL, Snyder AM, Stoddard GJ, Duffin KC, Hess R, Secrest A (2022). Evaluation of Skindex-16 construct validity in routinely collected psoriasis data: a retrospective analysis of the relationship between overall physician global assessment scores and Skindex-16 and measure discordance. Archives of dermatological research, 315(5), 1151-1159.
- Walsh JA, Callis Duffin K, Van Voorhees AS, Chakravarty SD, Fitzgerald T, Teeple A, Rowland K, Uy J, McLean RR, Malley W, Cronin A, Merola J (2022). Demographics, Disease Characteristics, and Patient-Reported Outcomes Among Patients with Psoriasis Who Initiated Guselkumab in CorEvitas' Psoriasis Registry. Dermatology and therapy, 12(1), 97-119.
- Taliercio VL, Snyder AM, Biggs AM, Kean J, Hess R, Duffin KC, Cizik AM, Secrest A (2021). Clinicians' perspectives on the integration of electronic patient-reported outcomes into dermatology clinics: a qualitative study. Quality of life research, 31(6), 1719-1725.
- Taliercio V, Langner AU, Secrest AM, Duffin K (2021). Assessing psoriasis severity: psychometric validation of overall physician global assessment (OPGA). Journal of the American Academy of Dermatology, 86(3), 637-638.
- Belman S, Walsh JA, Carroll C, Milliken M, Haaland B, Duffin KC, Krueger GG, Feng B (2021). Psoriasis Characteristics for the Early Detection of Psoriatic Arthritis. The Journal of rheumatology, 48(10), 1559-1565.
- Duffin KC, Gottlieb AB, O'Sullivan D, Gladman DD, McFarland L (2021). Prologue: 2020 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Journal of rheumatology. Supplement, 97, 1-3.
- Duffin KC, Bachelez H, Mease PJ, Rosen C, Garg A, Zudak E, Elkayam O, Merola JF, Chau J, Kishimoto M, Furer V, Helliwell P (2021). Pustular Psoriasis and Associated Musculoskeletal Disorders. The Journal of rheumatology. Supplement, 97, 34-38.
- Mease PJ, Calabrese LH, Duffin KC, Haberman RH, Firmino R, Scher JU, Schick L, Winthrop K, Merola J (2021). Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual Meeting. The Journal of rheumatology. Supplement, 97, 24-29.
- Callis Duffin K,Mason MA,Gordon K,Harrison RW,Crabtree MM,Guana A,Germino R,Lebwohl (2021). Characterization of Patients with Psoriasis in Challenging-to-Treat Body Areas in the Corrona Psoriasis Registry. Dermatology (Basel, Switzerland), 237(1), 46-55.
- Kornmehl H,Callis Duffin K,Salame N,Perez-Chada LM,Singh S,Garg A,Gottlieb AB,Latella J,Merola JF,Armstrong A (2021). Examination of Treatment Satisfaction Instruments in Psoriasis: 2017 Results from the Psoriasis Working Group of the International Dermatology Outcome Measures (IDEOM). Dermatology (Basel, Switzerland), 237(2), 151-157.
- Mease PJ, Calabrese LH, Callis Duffin K, Haberman RH, Firmino R, Scher JU, Schick L, Winthrop K, Merola J (2021). Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual Meeting. The Journal of rheumatology,
- Callis Duffin K, Bachelez H, Mease PJ, Rosen C, Garg A, Zudak E, Elkayam O, Merola J, Chau J, Kishimoto M, Furer V, Helliwell P (2021). Pustular Psoriasis and Associated Musculoskeletal Disorders. The Journal of rheumatology,
- Leung YY, Orbai AM, Tillett W, Ogdie A, Eder L, Goel N, Hojgaard P, Holland R, Mathew AJ, Lindsay CA, Antony A, Chau J, Christensen R, Coates LC, Mease PJ, Strand V, FitzGerald O, de Wit M, Callis Duffin K, Gladman D (2021). Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group. The Journal of rheumatology,
- Callis Duffin K, Gottlieb AB, O'Sullivan D, Gladman DD, McFarland L (2021). Prologue: 2020 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Journal of rheumatology,
- Perez-Chada LM, Gottlieb AB, Cohen J, Mease P, Duffin KC, Garg A, Latella J, Armstrong AW, Ogdie A, Merola J (2020). Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials. Journal of the American Academy of Dermatology, 82(1), 54-61.
- Taliercio V, Langner AU, Secrest AM, Duffin K (2020). Research Letter Measuring quality in psoriasis: early experiences with the MIPS 410 quality measure-cross sectional study. Journal of the American Academy of Dermatology, 88(5), 1119-1121.
- Gelfand JM, Shin DB, Duffin KC, Armstrong AW, Blauvelt A, Tyring SK, Menter A, Gottlieb S, Lockshin BN, Simpson EL, Kianifard F, Sarkar RP, Muscianisi E, Steadman J, Ahlman MA, Playford MP, Joshi AA, Dey AK, Werner TJ, Alavi A, Mehta N (2020). A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S). The Journal of investigative dermatology, 140(9), 1784-1793.e2.
- Perez-Chada LM, Salame NF, Ford AR, Duffin KC, Garg A, Gottlieb AB, Latella J, Merola JF, Armstrong A (2020). Investigator and Patient Global Assessment Measures for Psoriasis Clinical Trials: A Systematic Review on Measurement Properties from the International Dermatology Outcome Measures (IDEOM) Initiative. American journal of clinical dermatology, 21(3), 323-338.
- Carlisle RP, Flint ND, Hopkins ZH, Eliason MJ, Duffin KC, Secrest A (2020). Administrative Burden and Costs of Prior Authorizations in a Dermatology Department. JAMA dermatology, 156(10), 1074-1078.
- Blauvelt A,Papp K,Gottlieb A,Jarell A,Reich K,Maari C,Gordon KB,Ferris LK,Langley RG,Tada Y,Lima RG,Elmaraghy H,Gallo G,Renda L,Park SY,Burge R,Bagel J,Vender R,Lomaga MA,Delorme I,Hong CH,Langley RL,Albrecht L,Guenther L,Maari C,Papp K,Singh Ohson KK,Barber K,Lynde C,Gupta A,Rosoph L,Gauthier JS,Gooderham M,Wasel N,Raman M,Wiseman M,Greenstein D,Jarell A,Moon C,Clark L,Jazayeri SS,Bukhalo M,Moore A,Hamilton TK,Gewirtzman A,Hazan L,Crowley J,Teller C,Zirwas M,Smith SR,Christine Lee M,Tyring S,Lee P,Dhawan S,Leonardi C,Jesus APD,McFalda W,Frankel E,Yamauchi P,Fretzin S,Serrao R,Schlesinger T,Gottlieb S,Jenkin P,Gharib R,Davis S,Nami N,Draelos ZD,Godwin L,Owen C,Landis M,Abramovits W,Sanchez-Rivera S,Van Voorhees A,Fivenson D,Kerdel F,Forman SB,Weinberg J,Gonzalez-Chavez J,Boyce B,Stein-Gold L,Hudson C,Brown C,Coggi J,Feser C,Forconi R,Johnson S,McCune M,Green L,Madkan V,Shipp DM,Gordon KB,Waibel J,Soto-Raices O,Cather J,Miller S,Scott J,Young D,Kaffenberger J,Yokum (2020). A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial. The British journal of dermatology, 182(6), 1348-1358.
- Duffin KC,Gladman DD,Goel N,Gottlieb A (2020). Prologue: 2019 annual meeting of the group for research and assessment of psoriasis and psoriatic arthritis (grappa). The Journal of rheumatology, 96, 1-3.
- Coates LC,Merola JF,Grieb SM,Mease PJ,Duffin K (2020). Methotrexate in psoriasis and psoriatic arthritis. The Journal of rheumatology, 96, 31-35.
- Leung YY,Tillett W,Orbai AM,Ogdie A,Eder L,Coates LC,Holland R,Antony A,Goel N,Mease PJ,Strand V,FitzGerald O,De Wit M,Lindsay CA,Duffin KC,Gladman D (2020). The grappa-omeract working group: 4 prioritized domains for completing the core outcome measurement set for psoriatic arthritis 2019 updates. The Journal of rheumatology, 96, 46-49.
- Waxman R,Stober C,Jadon DR,Orbai AM,Chandran V,Ogdie A,Pennington SR,De Wit M,O'Sullivan D,Mease PJ,Armstrong AW,Callis Duffin K,Helliwell PS,Van Mens LJJ,Ritchlin CT,FitzGerald (2020). Proceedings of the 2019 grappa collaborative research network meeting. The Journal of rheumatology, 96, 25-30.
- Noe MH, Wan MT, Shin DB, Armstrong AW, Duffin KC, Chiesa Fuxench ZC, Kalb RE, Menter A, Simpson EL, Takeshita J, Tyring SK, Van Voorhees AS, Mehta NN, Gelfand J (2019). Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study. Journal of the American Academy of Dermatology, 81(4), 923-930.
- Perez-Chada L, Taliercio VL, Gottlieb A, Van Beek M, Duffin KC, Reeder M, Merola JF, Swerlick R (2019). Achieving Consensus on Patient-Reported Outcome Measures in Clinical Practice for Inflammatory Skin Disorders: On Behalf of International Dermatology Outcome Measures and the American Academy of Dermatology. Journal of the American Academy of Dermatology, 88(1), 86-93.
- Leung YY, Orbai AM, Ogdie A, Coates LC, de Wit M, Callis Duffin K, Eder L, Gladman DD, Goel N, Mease PJ, Strand V, FitzGerald O, Tillett (2019). The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set. The Journal of rheumatology. Supplement, 95, 33-37.
- Jadon DR, Chandran V, Ogdie A, Pennington SR, Stober C, Gladman DD, de Wit M, O'Sullivan D, Mease P, Armstrong AW, Callis Duffin K, Magee C, Helliwell P, Ritchlin CT, FitzGerald (2019). Proceedings of the 2018 GRAPPA Collaborative Research Network Meeting. The Journal of rheumatology. Supplement, 95, 11-19.
- Callis Duffin K, Gladman DD, Gottlieb AB, Goel (2019). Prologue: 2018 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Journal of rheumatology. Supplement, 95, 1-3.
- Callis Duffin K, Bushmakin AG, Cappelleri JC, Mallbris L, Mamolo (2019). A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies. BMC dermatology, 19(1), 8.
- Strober B, van de Kerkhof PCM, Callis Duffin K, Poulin Y, Warren RB, de la Cruz C, van der Walt JM, Stolshek BS, Martin ML, de Carvalho AV (2019). Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council. American journal of clinical dermatology, 20(5), 699-709.
- Duffin KC Md M (2015). Screening and Monitoring Before and During Systemic Therapy: Recommendations for Patients With Psoriasis. Seminars in cutaneous medicine and surgery, 34(2 Suppl), S40-2.
- Duffin KC Md M (2015). Identifying and Managing Complications and Comorbidities in Patients With Psoriasis. Seminars in cutaneous medicine and surgery, 34(2 Suppl), S30-3.
- Yeung H, Wan J, Van Voorhees AS, Callis Duffin K, Krueger GG, Kalb RE, Weisman JD, Sperber BR, Brod BA, Schleicher SM, Bebo BF Jr, Shin DB, Troxel AB, Gelfand J (2013). Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis. Journal of the American Academy of Dermatology, 68(1), 64-72.
- Walsh JA, Callis Duffin K, Krueger GG, Clegg D (2013). Limitations in screening instruments for psoriatic arthritis: a comparison of instruments in patients with psoriasis. The Journal of rheumatology, 40(3), 287-93.
- Armstrong AW, Parsi K, Schupp CW, Mease PJ, Duffin K (2013). Standardizing training for psoriasis measures: effectiveness of an online training video on Psoriasis Area and Severity Index assessment by physician and patient raters. JAMA dermatology, 149(5), 577-82.
- Jordan CT, Cao L, Roberson ED, Duan S, Helms CA, Nair RP, Duffin KC, Stuart PE, Goldgar D, Hayashi G, Olfson EH, Feng BJ, Pullinger CR, Kane JP, Wise CA, Goldbach-Mansky R, Lowes MA, Peddle L, Chandran V, Liao W, Rahman P, Krueger GG, Gladman D, Elder JT, Menter A, Bowcock A (2012). Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis. American journal of human genetics, 90(5), 796-808.
- Hsu S, Papp KA, Lebwohl MG, Bagel J, Blauvelt A, Duffin KC, Crowley J, Eichenfield LF, Feldman SR, Fiorentino DF, Gelfand JM, Gottlieb AB, Jacobsen C, Kalb RE, Kavanaugh A, Korman NJ, Krueger GG, Michelon MA, Morison W, Ritchlin CT, Stein Gold L, Stone SP, Strober BE, Van Voorhees AS, Weiss SC, Wanat K, Bebo BF J (2012). Consensus guidelines for the management of plaque psoriasis. Archives of dermatology, 148(1), 95-102.
- Gelfand JM, Wan J, Callis Duffin K, Krueger GG, Kalb RE, Weisman JD, Sperber BR, Stierstorfer MB, Brod BA, Schleicher SM, Bebo BF Jr, Troxel AB, Shin DB, Steinemann JM, Goldfarb J, Yeung H, Van Voorhees A (2012). Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting. Archives of dermatology, 148(4), 487-94.
- Callis Duffin K, Mease P (2011). Psoriasis and Psoriatic Arthritis Video Project 2010: a report from the GRAPPA annual meeting. The Journal of rheumatology, 38(3), 562-3.
- Wong B, Machan M, Krueger GG, Callis Duffin (2011). Increased Prevalence of Sleep Disorders and Medical Comorbidities in Psoriatic Arthritis Patients Compared with Patients With and Without Psoriasis. Psoriasis forum, 17(3), 209-215.
- Narayanan S, Callis-Duffin K, Batten J, Agarwal (2010). Improvement of psoriasis during sunitinib therapy for renal cell carcinoma. The American journal of the medical sciences, 339(6), 580-1.
- Nair RP, Ding J, Duffin KC, Helms C, Voorhees JJ, Krueger GG, Bowcock AM, Abeçasis GR, Elder J (2009). Psoriasis bench to bedside: genetics meets immunology. Archives of dermatology, 145(4), 462-4.
- Callis Duffin K, Wong B, Horn EJ, Krueger G (2009). Psoriatic arthritis is a strong predictor of sleep interference in patients with psoriasis. Journal of the American Academy of Dermatology, 60(4), 604-8.
- Duffin KC, Freeny IC, Schrodi SJ, Wong B, Feng BJ, Soltani-Arabshahi R, Rakkhit T, Goldgar DE, Krueger G (2009). Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking. The Journal of investigative dermatology, 129(12), 2777-83.
- Feng BJ, Sun LD, Soltani-Arabshahi R, Bowcock AM, Nair RP, Stuart P, Elder JT, Schrodi SJ, Begovich AB, Abecasis GR, Zhang XJ, Callis-Duffin KP, Krueger GG, Goldgar D (2009). Multiple Loci within the major histocompatibility complex confer risk of psoriasis. PLoS genetics, 5(8), e1000606.
- Grande-Sarpa H, Callis Duffin KP, Florell S (2008). Onychodystrophy and tumor-stage mycosis fungoides confined to a single digit: report of a case and review of nail findings in cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology, 59(1), 154-7.
Review
- Armstrong AW, Blauvelt A, Callis Duffin K, Huang YH, Savage LJ, Guo L, Merola J (2025). Psoriasis. Nature reviews. Disease primers, 11(1), 45.
- Choon SE,Van De Kerkhof P,Gudjonsson JE,De La Cruz C,Barker J,Morita A,Romiti R,Affandi AM,Asawanonda P,Burden AD,Gonzalez C,Marrakchi S,Mowla MR,Okubo Y,Oon HH,Terui T,Tsai TF,Callis-Duffin K,Fujita H,Jo SJ,Merola J,Mrowietz U,Puig L,Thaçi D,Velásquez M,Augustin M,El Sayed M,Navarini AA,Pink A,Prinz J,Turki H,Magalhães R,Capon F,Bachelez (2024). International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis from the International Psoriasis Council. JAMA dermatology, 160(7), 758-768.
- Duffin KC, Thio HB, Helliwell P (2024). Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis, Palmoplantar Pustulosis, and Neutrophilic Dermatoses: A GRAPPA 2023 Annual Meeting Update. The Journal of rheumatology, 51(Suppl 2), 77-79.
- Ball GD, Hamade H, Gottlieb AB, Kirby B, Duffin K (2024). GRAPPA Point-Counterpoint: Should Biologics Be Used for Mild Psoriasis?. The Journal of rheumatology, 51(Suppl 2), 39-42.
- Duffin KC, Mazzuoccolo LD, Cura MJ, Esposito M, Fernandez AP, Gisondi P, Giunta A, Hillary T, Piaserico S, Solomon JA, Merola J (2023). Treatment of Psoriasis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. The Journal of rheumatology, 50(1), 131-143.
- deShazo RA,Secrest AM,Armstrong AW,Duffin K (2020). Addressing Hypertension in Patients With Psoriasis: Review and Recommendations. Journal of psoriasis and psoriatic arthritis,
- Salame N, Torres J, Sandhu J, Callis Duffin K, Garg A, Gottlieb AB, Latella J, Merola JF, Armstrong A (2018). Patient-Reported Outcome Measures for Pediatric Psoriasis: A Systematic Review and Critical Appraisal from International Dermatology Outcome Measures (IDEOM). Dermatology (Basel, Switzerland), 234(3-4), 112-119.
Book Chapter
- DeShazo R (2014). Topical Agents. Moderate to Severe Psoriasis Fourth Edition, 41-65.
Conference Proceedings
- Duffin KC,Mease P (2015). Psoriasis and psoriatic arthritis educational initiatives: An update from the 2014 GRAPPA annual meeting. The Journal of rheumatology, 42(6), 1056-1058.
Editorial
- Hopkins ZH, Perez Chada LM, Duffin K (2023). Defining what matters through core outcomes set development: Uniting stakeholder perspectives, empowering patient voices. The British journal of dermatology,
Letter
- Romagosa R,Kerdel F,Shah N,Krueger G,Callis (2002). Treatment of psoriasis with 6-thioguanine and hepatic venoocclusive disease [6]. Journal of the American Academy of Dermatology, 47(6), 970-972.
Other
- Leung YY, Orbai AM, Tillett W, Ogdie A, Eder L, Goel N, Hojgaard P, Holland R, Mathew AJ, Lindsay CA, Antony A, Chau J, Christensen R, Coates LC, Mease PJ, Strand V, FitzGerald O, de Wit M, Duffin KC, Gladman D (2021). Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group. The Journal of rheumatology. Supplement, 97, 60-63.
News & Podcasts
News
- Chair of Department of Dermatology Named at University of Utah
- Patrol Your Moles: What They Mean for Your Skin Health
- Kristina Callis Duffin, MD, MS, appointed Interim Dean of the Spencer Fox Eccles School of Medicine at the University of Utah
- Kristina Callis Duffin, MD, MS, Named Dean of the Spencer Fox Eccles School of Medicine at the University of Utah
I've been treated by Dr Duffin for several years now. I find her engaged, friendly, and very professional¿.if she was any different, I would not still be her patient.
The U Health people are ALL so caring and listen to your concerns & questions with care & helpful in any way they can! If your looking for dermatology help, we recommend their office for tender, loving, care!!!!
Dr. Callis Duffin is an excellent provider. She's personable and explains things well. Totally relaxed in her care.
She gave me the first correct diagnosis and got me on a plan that worked. I even moved away to Florida and her care was so good I would fly back to Utah for treatment. She is a brilliant Doctor and an honor to have her care.
Highly recommend Dr Callis Diffin. Such a caring and knowledgeable physician.
The best
Dr Callis is amazing. Always spot on.
I feel very fortunate to have Dr. Callis as my dermatologist.
Dr. Callis Duffin is very thorough and is excellent at explaining particular issues. I feel great confidence in her care.
Dr Kristina has been caring for me for about 10 years now! She's always been great in taking care of my psoriasis problems.
Kind and knowledgeable care provider
Dr callis is the best.
I have seen Dr Callis Duffin for several years and have ALWAYS had a positive experience! She's the best!!
Dr Callis listened to my concerns and expressed positive suggestions as to what options I have to continue her treatment for my psoriasis condition.
Very personable and is great to work with. No anxiety about having to deal with a crusty robot.
Dr Callis-Duffin has been my doctor for over 30 years. She is excellent!
Dr Callis Duffin was extremely knowledgeable in the treatment of psoriasis. I went to her to get a second opinion on my disease, she concurred with my physician in Billings, MT that we were on the right track in our treatment regimen. She also let me know that if treatment ceased to work efficiently that there are other medications available. I appreciated her taking time to answer my questions and give me a handout with information pertaining to different groups of medications.
I trust Dr Callis-Duffin completely with my dermatology needs. She found a cancerous mole on my back that I would have never seen. I feel that she saved my life!! Now I come for yearly checks and she is very thorough in making sure I'm healthy!
Very knowledgeable and considerate of how treatment would affect me
I have been seeing Dr. Callis Duffin for a yearly skin check for over 20 years. She is always thorough, courteous, professional and explains things in an understandable way.
Awesome
She is the BEST in her field & we hope to be able to continue with her for many more years, if you donÕt get it we REALLY like her!!!!
Skilled and with great expertise she and her team treated our skin and conditions perfectly.
Excellent provider. Kind, personable, includes patient in decision making.
The first time meeting Dr Callis Duffin. She was friendly, kind and very professional explaining my condition, listening to my questions, and going over my treatment plan.
She's professional but most important she's friendly, easy to talk to. She explains everything as she's doing it, includes you in her plan of care and answers any questions you have.
I can't say enough good things about Dr. Callis Duffin. I feel very fortunate to have her as my doctor. She was the first one to really take my psoriasis seriously and work to find an effective solution.
She is the best!
Dr Callis is a great doctor. always listens to my concerns. Thank you
Dr. Callis listens to her patients needs. She understands psoriasis greatly and her and her team are very responsive to questions and inquiries.
Dr. Duffin is always friendly and knowledgeable. I feel confident that I'm getting great care.
Dr. Calais Duffin is without a doubt the best dermatologist for me. Her expertise is unmatched, and I have complete confidence in her abilities.
She was absolutely amazing, knew what she was talking about and solved my problem I've had for 11 years.
Doctor Duffin is caring and very helpful.
Love this practice and Dr. Callis! She saved my lifte!
Dr. Callis Duffin is truly one of the most amazing healthcare professionals that has ever cared for me. She has always listened to, and cared for any concern that I have ever had. I have always had the attention I have needed, and have been treated with such amazing respect, kindness, and compassion. I truly enjoy coming to this clinic every time.
Thoughtful and patient. Listened to me and took my concerns seriously.
She is very knowledgeable about Psoriasis
Love my visits to Dr Callis Duffin! I get great care and always leave feeling good about my condition!
Kristina Callis Duffin, MD is a great Doctor, She cares about her patients and will always do the best s he can for them She explains what needs to happen and always lets you know that it is your choice.
Dr. Callis Duffin is kind and competent. I recommend her without reservation.
Great listener, knowledgeable, explains things clearly.
Dr. Callis and her Team are the best. All are great to work with, and they extend the dignity and respect one would expect.
Dr. Duffin is knowledgeable & friendly. She patiently answered all my questions.
We love Dr. Call is Duffin, we have been coming to her for years!
Dr. Callis Duffin is an excellent dermatologist. Personable, listens, clear explanations.
I always look forward to and appreciate the fine care we receive.
She has always been very caring to me and vigilant in solving my Psoriasis issues. She has made my life very comfortable considering the severity of my skin condition issues which were pretty terrible years ago. I will always be grateful for Dr Kristina's care.
Very caring
She has always provided me with excellent care. Answers all my questions.
She explained things clearly and with consideration. She is kind, clearly knowledgeable, and very skilled. I am very grateful for her.
I have always felt comfortable talking to my doctor. She has listened and offered treatments regarding my condition.
Dr. Callis Duffin is attentive, engaging, and professional, taking time to connect with patients and understand any concerns. She has knowledge, skill, and experience that I trust and respect. In my case she provided treatment options and recommendations.
I trust her knowledge and experience. I've been seeing her for many years.
She always listens to my concerns. She takes time and explains things I might not understand. She is very helpful in resolving problems going forward. Friendly and fun to talk to.
She is AWESOME!
Listens, acts and treats all with respect and dignity
As I previously mentioned, Dr. Callis is a true professional and a great mentor to others.
As I mentioned at the beginning of the survey, Dr. Callis is always very professional and takes the time to explain things so I can understand.
Dr Duffin was prompt, explained things clearly and concisely. She had time for my questions.
Outstanding provider! Dr. Callis-Duffin is pleasant, personable, and always takes the time necessary to treat any pending skin issues. It's a privilege to be one of her patients!
Very knowledgeable
Always very helpful and caring
My appointment with her was excellent. She answered all my questions, listened and truly cared about my current situation. I left feeling satisfied, cared for and optimistic about my future skin condition. Highly recommend.
Dr. Callis Duffin has been my doctor for more than 10 years. I find her to be very good at what she does. She is also thoughtful and caring and listens to what you have to say.
I have seen Dr. Callis for a long time and I really like her.
I have been seeing Dr Kristina Callis Duffin for several years and enjoyed tremendous success with the treatment of my psoriasis. I feel privileged to have a doctor that really cares. It has been a pleasant experience.
Kristina is awesome!!!
She is the best
I have been seeing her for 6 years and she has done a remarkable job.
World class expertise. She really knows her stuff and if she doesnt have all the answers herself, she knows where to direct you to find them. Shes efficient and offers great recommendations/care options with pros and cons so that informed decisions can be made. She does a great job leveraging her staff to speed up some of the processes associated with receiving medications while reducing or even cutting prescription costs. I love that she cares about that! Her bedside manner is great and my mental health has improved since Ive been visiting.
I trust DR. Callis-Duffin. She listens to my concerns and addresses them with a treatment plan, ususal with options that we talk about and determine how to proceed.
Thank you
The customer service at the check could be friendlier and more professional
Dr Kristina is very good, knows her patients needs and is always very personable.
Good
Dr. Callis always has been very attentive to my needs.
Dr. Callas is excellent!
I was so thankful that I could talk to Dr. Duffin so quickly. Her response helped my anxiety and gave me some relief.
She's the best
Dr. Callis-Duffin is always thorough and gives an explanation that is easily understood.
Dr. Callis Duffin is competent and cordial.
Dr. Callis changed some meds and it was taken care of very efficiently.
Dr. Callis rocks!
Dr. Callis has a great way with patients (or at least with me). I am at ease with her examining me, even very private areas. She always explains who the other people are who accompany her (usually a med student) and always ask if they can examine me as well. I don't mind being a training aid for her students. That is not true of all my other doctors.
We have been very impressed With our doctor and staff/students with her
Very good visit
Dr. Callis is never satisfied with ok . She always strives for perfection.
Dr Callis Duffin is excellent. I get all my questions answered thoroughly and I know she knows the latest research and information in her field. I trust her advice more than any other doctor I have worked with.
I love dr Callis!
good
Dr. Callis Duffin is excellent with explaining assessment and treatment.
The doctor has lots of experience and is knowledgeable on all the medical subjects I have asked him about. That gives me reassurance that I am getting good care,
Dr Callis gave me insight into some ongoing health problems that really helped me understand.
Dr. Callis and her staff are always thorough and compassionate
Phenomenal experience with doctor.
thorough
they were so nice!
Dr. Callis is able to use her training, knowledge, and wisdom extremely well and in a very pleasant manner.
Dr. Callas is amazing! I truly appreciate he knowledge, her careful examinations, her finding and treating my skin cancers, and her positivity! I have recommended her to many friends and family members!!
visit with Doc seemed a bit rushed.
Dr. Callis was excellent, paid attention to detail, answered all questions and is very knowledgeable.
I already knew most of what she said, however it was good to get a second opinion.
very professional and caring
I mentioned concern about Shingles since my wife has it. Dr explained in detail vaccines and even provided a detailed report to me before leaving .
ok
I had to start on a new drug, She was great in giving me the information about the new drug and also answered all the questions I asked.
Dr. Call is always treats the patient not just the condition.
still need to know when drug administered to me (Skyrixz) takes effect , what results and prognosis will be for my awful psoriasis
excellent medical advice. I only receive the best care from Dr. Callis-Duffin
Dr. Callis is wonderful. I have seen many doctors over the years for my psoriasis and she is the first one who seemed to actually be determined to develop a plan to get it under control.
This was the best doctor/patient experience I have had in a very long time.
I'm very happy with the level of care that my doctor has provided.
I really appreciate that Dr. Callis was available to do a virtual visit with me. I am considered a high risk and I am taking all of the precautions very seriously. I am not ready to cross state lines yet for my medical care and this allowed me to still be seen and to discuss any issues I might be having.
Dr callis is always very thourough
superb
always amazed at the care I receive from everyone at my appointments.
Appreciate problem solving efforts regarding access to derma care when I live out in the boonies.
My appointment was just a check up, although I was pleased that the doctor did not see any new issues
Dr. Callas and her team are the best!
Dr Callis-Duffin was the best as usual.
one of my favorite doctors
Dr Duffin was great. Have gone to her for several years and always felt great about her care
The Doctor always listens to my questions and worries . she made some recommendations to me about my care and I listen carefully and took her recommendation. She is a great Doctor, I have been seeing her for about 9Yrs.
Dr Callis Duffin is great. She answers all my questions and educates me on the latest research and treatment options for my condition.
great